CorMedix (CRMD) News Today $11.27 +0.18 (+1.62%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$11.34 +0.07 (+0.63%) As of 05:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRMD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period CorMedix (NASDAQ:CRMD) Downgraded to Hold Rating by Zacks ResearchOctober 8 at 7:44 AM | marketbeat.comCorMedix (NASDAQ:CRMD) Downgraded to "Buy" Rating by Wall Street ZenOctober 3, 2025 | marketbeat.comCorMedix (CRMD): Assessing Valuation After Recent Volatility and Analyst Price TargetsOctober 3, 2025 | finance.yahoo.comCorMedix (NASDAQ:CRMD) Stock Price Down 3.5% - What's Next?October 1, 2025 | marketbeat.comCorMedix files to sell 6.32M shares of common stock for holdersOctober 1, 2025 | msn.comHC Wainwright Increases Earnings Estimates for CorMedixSeptember 30, 2025 | americanbankingnews.comCorMedix completes enrollment in Phase III ReSPECT trial for REZZAYOSeptember 29, 2025 | msn.comCorMedix Inc. Completes Enrollment in Phase III ReSPECT Study for REZZAYO® in Fungal Infection Prophylaxis, Topline Results Expected 2Q 2026September 29, 2025 | quiverquant.comQCorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYOSeptember 29, 2025 | globenewswire.comFY2025 EPS Estimates for CorMedix Boosted by HC WainwrightSeptember 29, 2025 | marketbeat.comPalisades Investment Partners LLC Has $6.93 Million Position in CorMedix Inc $CRMDSeptember 28, 2025 | marketbeat.comHC Wainwright Has Positive Outlook for CorMedix Q3 EarningsSeptember 28, 2025 | americanbankingnews.comHC Wainwright Has Positive Estimate for CorMedix Q3 EarningsSeptember 26, 2025 | marketbeat.comLeerink Partners Sticks to Their Buy Rating for Cormedix (CRMD)September 25, 2025 | theglobeandmail.comQ3 Earnings Estimate for CorMedix Issued By Leerink PartnrsSeptember 25, 2025 | marketbeat.comCorMedix Inc (NASDAQ:CRMD) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesSeptember 23, 2025 | marketbeat.comCorMedix: Strong Adoption Curve And Policy EnvironmentSeptember 22, 2025 | seekingalpha.comInsider Decision Making Waves At Cormedix: Gregory Scott Duncan Exercises Options, Realizing $45KSeptember 20, 2025 | benzinga.comCorMedix (NASDAQ:CRMD) Director Alan Dunton Sells 10,000 SharesSeptember 17, 2025 | marketbeat.comCitizens JMP Reiterates a Buy Rating on CorMedix Inc. (CRMD)September 17, 2025 | insidermonkey.comCorMedix (NASDAQ:CRMD) Stock Price Down 5.3% - Here's What HappenedSeptember 17, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Director Sells $131,300.00 in StockSeptember 17, 2025 | insidertrades.comSwedbank AB Makes New $1.54 Million Investment in CorMedix Inc $CRMDSeptember 17, 2025 | marketbeat.comTaking a Fresh Look at CorMedix (CRMD) Valuation as Investor Sentiment Quietly ShiftsSeptember 15, 2025 | finance.yahoo.comCorMedix (NASDAQ:CRMD) Stock Rating Upgraded by Wall Street ZenSeptember 15, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) CEO Sells $650,000.00 in StockSeptember 13, 2025 | insidertrades.comMajor Exercise Alert: Beth Zelnick Kaufman Exercises Options Worth $495K At CormedixSeptember 12, 2025 | benzinga.comStrategic Sale: Elizabeth Hurlburt Decides To Exercise Options Worth $635K At CormedixSeptember 12, 2025 | benzinga.comCorMedix Inc. Stock (CRMD) Opinions on Recent Analyst Rating UpgradeSeptember 12, 2025 | quiverquant.comQCorMedix (NASDAQ:CRMD) COO Sells $173,954.76 in StockSeptember 12, 2025 | insidertrades.comCorMedix (NASDAQ:CRMD) Trading Up 4.5% - Here's What HappenedSeptember 11, 2025 | marketbeat.comCorMedix Inc (NASDAQ:CRMD) Short Interest UpdateSeptember 11, 2025 | marketbeat.comCorMedix's (CRMD) Market Outperform Rating Reiterated at JMP SecuritiesSeptember 11, 2025 | marketbeat.comCormedix (CRMD) Gets a Buy from Citizens JMPSeptember 11, 2025 | theglobeandmail.comCorMedix Inc. (CRMD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comAnalyst Expectations For Cormedix's FutureSeptember 9, 2025 | benzinga.comTrexquant Investment LP Increases Stake in CorMedix Inc $CRMDSeptember 9, 2025 | marketbeat.comCormedix (CRMD) Gets a Buy from Truist FinancialSeptember 8, 2025 | theglobeandmail.comCorMedix Inc. Makes $5 Million Strategic Investment in Talphera, Inc. to Support Development of Niyad™September 8, 2025 | quiverquant.comQCorMedix Announces Strategic Minority Investment in TalpheraSeptember 8, 2025 | globenewswire.comGraham Capital Management L.P. Makes New $648,000 Investment in CorMedix Inc $CRMDSeptember 8, 2025 | marketbeat.comInstitutional Confidence Rises as CorMedix Inc. (CRMD) Hits ProfitabilitySeptember 5, 2025 | finance.yahoo.comCaption Management LLC Makes New $113,000 Investment in CorMedix Inc $CRMDSeptember 4, 2025 | marketbeat.comCorMedix Inc $CRMD Shares Sold by Elliott Investment Management L.P.September 3, 2025 | marketbeat.comCorMedix Completes Acquisition of Melinta TherapeuticsSeptember 2, 2025 | tipranks.comCorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership TeamSeptember 2, 2025 | globenewswire.comInvesco Ltd. Increases Stake in CorMedix Inc $CRMDSeptember 2, 2025 | marketbeat.comNuveen LLC Buys New Position in CorMedix Inc $CRMDSeptember 1, 2025 | marketbeat.comCorMedix Inc (NASDAQ:CRMD) Given Average Recommendation of "Moderate Buy" by BrokeragesAugust 31, 2025 | marketbeat.comVanguard Group Inc. Buys 268,360 Shares of CorMedix Inc $CRMDAugust 31, 2025 | marketbeat.com Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRMD Media Mentions By Week CRMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRMD News Sentiment▼-0.180.63▲Average Medical News Sentiment CRMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRMD Articles This Week▼46▲CRMD Articles Average Week Get the Latest News and Ratings for CRMD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CorMedix and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies LNTH News TLX News ADMA News AMRX News INDV News CNTA News APLS News XENE News RARE News CGON News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRMD) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorMedix Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share CorMedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
